A retrospective feasibility study of biweekly, reduced-dose docetaxel in Asian patients with castrate-resistant, metastatic prostate cancer.

Hae Su KimJi Yun LeeSu Jin LeeHo Yeong LimHyun Hwan SungHwang Gyun JeonByong Chang JeongSeong Il SeoSeong Soo JeonHyun Moo LeeHan-Yong ChoiSe Hoon Park

Published in: BMC urology (2017)

Within the limitations of a retrospective study, the biweekly reduced dose docetaxel regimen was active and well-tolerated in Korean patients with metastatic CRPC.

Keyphrases

prostate cancer
locally advanced
squamous cell carcinoma
radical prostatectomy
small cell lung cancer
rectal cancer
radiation therapy